Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase 3 randomized trial

Ghia, P, Coutre, SE, Cheson, BD et al. (7 more authors) (2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase 3 randomized trial. Haematologica. ISSN 0390-6078

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020, Ferrata Storti Foundation. This is an open access article.
Keywords: chronic lymphocytic leukemia; quality of life; idelalisib
Dates:
  • Accepted: 7 February 2020
  • Published (online): 13 February 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 27 Jan 2020 13:54
Last Modified: 20 Mar 2020 10:48
Status: Published online
Publisher: Ferrata Storti Foundation
Identification Number: https://doi.org/10.3324/haematol.2019.238808

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)